Hematopoiesis News Volume 14.30 | Aug 01 2023

    0
    15








    2023-08-01 | HN 14.30


    Hematopoiesis News by STEMCELL Technologies
    Vol. 14.30 – 1 August, 2023
    TOP STORY

    In Vivo Hematopoietic Stem Cell Modification by mRNA Delivery

    Researchers developed CD117/LNP–mRNA, a lipid nanoparticle that encapsulated mRNA and was targeted to the stem cell factor receptor, CD117, on HSCs.
    [Science]

    AbstractPress Release
    Explore the Science Events Calendar to discover conferences, podcasts, webinars, and more!
    PUBLICATIONSRanked by the impact factor of the journal

    Assessment of Stored Red Blood Cells through Lab-on-a-Chip Technologies for Precision Transfusion Medicine

    The authors imagined a future where lab-on-a-chip technologies utilized novel predictive markers of red blood cell quality identified by -omics and machine learning to usher in a new era of safer and precise transfusion medicine.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    AbstractPress Release

    MBTD1 Preserves Adult Hematopoietic Stem Cell Pool Size and Function

    Researchers generated malignant brain tumor domain containing 1 (Mbtd1) conditional knockout mice and analyzed adult hematopoietic tissues deficient in Mbtd1.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    DNAJC10 Maintains Survival and Self-Renewal of Leukemia Stem Cells through PERK Branch of the Unfolded Protein Response

    Scientists found that DNAJC10, a member of HSP40 family, was frequently upregulated in various types of AML and in leukemia stem cell-enriched cells.
    [Haematologica]

    Abstract

    Arginine Dependency Is a Therapeutically Exploitable Vulnerability in Chronic Myeloid Leukemic Stem Cells

    Researchers performed an amino acid drop-out screen and applied pre-clinical models of chronic phase chronic myeloid leukemia (CML) to identify arginine as a nutrient essential for primary human CML cells.
    [EMBO Reports]

    Full ArticleGraphical Abstract

    Prognostic and Therapeutic Implications of Iron-Related Cell Death Pathways in Acute Myeloid Leukemia

    Investigators examined the clinical significance of genes involved in iron-related cell death and apoptotic pathways in AML, with the intention of providing insights that could have prognostic implications and facilitate the development of targeted therapeutic interventions.
    [Frontiers in Oncology]

    Abstract

    The E3 Ligase DTX2 Inhibits RUNX1 Function by Binding Its C-Terminus and Prevents the Growth of RUNX1-Dependent Leukemia Cells

    Scientists examined whether DTX2 was involved in the regulation of RUNX1 using in vitro and ex vivo analyses. DTX2 bound to RUNX1 and other RUNX family members RUNX2 and RUNX3 through their C-terminal region.
    [FEBS Journal]

    Abstract

    Perturbed Epigenetic Transcriptional Regulation in AML with IDH Mutations Causes Increased Susceptibility to NK Cells

    Researchers characterized the transcriptional and epigenetic landscape with the isocitrate dehydrogenase (IDH) 2i AG-221, using an IDH2 mutated AML cell line model and AML patient cohorts.
    [Leukemia]

    Full Article

    Subclones with Variants of Uncertain Clinical Significance Might Contribute to Ineffective Hemopoiesis and Leukemia Predisposition

    A total of 59 consecutive subjects diagnosed with myelodysplasia, 48 with AML, and 17 with clonal cytopenia with unknown significance were screened for somatic mutations in AML-related genes by next-generation sequencing.
    [European Journal of Haematology]

    Full Article

    Banner Ad Cross Reference Banner Ad Cross Reference 100% 10 E17 Visit the Hematopoiesis Resource Center for videos, tips, and protocols to help with your research questions. Screen reader support enabled. Visit the Hematopoiesis Resource Center for videos, tips, and protocols to help with your research questions. Turn on screen reader support
    REVIEWS

    Transposable Elements in Normal and Malignant Hematopoiesis

    Transposable elements play a role in hematopoiesis, especially during periods of high cellular plasticity, such as development, regeneration, and aging.
    [Disease Models & Mechanisms]

    Full Article
    INDUSTRY AND POLICY NEWS

    Senate Panel Approves 2% Bump for NIH Budget in 2024

    Although below the rate of biomedical inflation, it is far more generous than a corresponding House of Representatives bill that would slash NIH’s budget by 6%.
    [Science Insider]

    Editorial
    FEATURED EVENT

    4th International Conference on Lymphocyte Engineering

    September 12 – 14, 2023
    Munich, Germany

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Project Research Scientist – Signaling and Structural Laboratory

    Francis Crick Institute – London, England, United Kingdom

    Postdoctoral Position – Proteostasis, Hematopoiesis, and AML

    National Institutes of Health – Bethesda, Maryland, United States

    Hematologist – Allogeneic HSCT, Myeloid Neoplams

    University of Alberta – Edmonton, Alberta, Canada

    Scientific Director – Clinical Research

    NCI Center for Cancer Research – Bethesda, Maryland, United States

    Associate Professor – Pediatric Blood and Marrow Transplantation

    Fred Hutchinson Cancer Center – Seattle, Washington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hematopoiesis News Twitter